Objective 1 To pilot test the efficacy of the interactive voice response (IVR) intervention for improving pain management and quality of life of underserved minority patients with breast cancer, as compared to the current standard of care.

Objective 2 To pilot test the efficacy of the IVR intervention for improving pain-related symptoms (fatigue, sleep disturbance, sadness) of underserved minority patients with breast cancer, as compared to the current standard of care.

Secondary Objective:

Objective 3 To evaluate the feasibility of an IVR intervention for pain management that targets both underserved minority patients with breast cancer and their health care providers.

Hypotheses:
1. Minority breast cancer patients randomly assigned to the IVR intervention group will demonstrate improved pain management and quality of life, as compared to patients in the control group.
2. Minority breast cancer patients randomly assigned to the IVR intervention group will demonstrate reductions in pain-related symptoms (fatigue, sleep disturbance, sadness), as compared to patients in the control group.
3. Minority breast cancer patients in the IVR intervention group will demonstrate improved communication with their physicians, as demonstrated by greater concordance in physician and patient ratings of patients' pain and by improvements in the adequacy of prescribed analgesics and analgesic doses.
4. Minority breast cancer patients in the IVR intervention group will demonstrate reductions in self-reported barriers to optimal pain management, as compared to patients in the control group.
5. The feasibility of the IVR intervention for underserved African American and Hispanic patients will be demonstrated by good rates of patient recruitment and retention, patient adherence to the IVR call schedule, and patient evaluation of the IVR intervention. The feasibility also will be evaluated by provider responses to the IVR alerts and prompts for clinical practice guidelines.